FOR IMMEDIATE RELEASE

NEW YORK, NY | Stockholm, Sweden – Abe Kasbo, CEO of Verasoni Worldwide, has been named as a panelist at the Swedish-American Life Sciences Summit 2011. The Summit will take place on August 24-26, 2011 in Stockholm, Sweden.

Kasbo will be a featured speaker on the panel “A Shifting Industry – Trends & Opportunities in the Coming Decade” where he will discuss the impact of the changing roles of marketing communications relative to how healthcare and life sciences companies reach investors and patients.

“It’s an honor to be part of a distinguished panel and contributing to this timely topic. This discussion could not be more fitting relative to near and long-term market trends and the implications are many,” said Mr. Kasbo.  Distinguished speakers include: Göran Hägglund, Sewdish Minister for Health and Social Affairs, Fred Hassan, Chairman, Bausch and Lomb Dr. Mikael Dolsten, President Worldwide R&D, Pfizer, Dr. William A. Haseltine, Chairman, Haseltine Global Health, Professor Mathias Uhlén, The Royal Institute of Technology.  The Swedish American Life Sciences Summit began in 2005 to connect the US market with the Swedish life sciences industry.

This year’s keynote topic is “What to Expect in a Rapidly Changing Life Science World”, presented by Richard Bergström, Director General of European Federation of Pharmaceutical Industries and Associations. Other topics include the future of the pharmaceutical industry, emerging technologies in cancer treatment and global health trends.

For more information about the Summit, visit: http://www.salss.com. For more information on Verasoni Worldwide, please visit http://www.verasoni.com